Spoken Alpha
MTVA
MetaVia Inc.
Overview
MetaVia develops novel pharmaceuticals to treat cardiometabolic diseases, with two lead programs: vanoglipel (DA-1241), a GPR119 agonist in Phase 2a trials for metabolic dysfunction-associated steatohepatitis and Type 2 diabetes, and DA-1726, a GLP-1/glucagon receptor dual agonist in Phase 1 trials for obesity.
MetaVia Inc is a Healthcare company operating in Biotechnology with a $10.3M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 4, 2026).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
Recent earnings calls
No earnings calls indexed for MTVA yet
We index calls for roughly 3,000 US-listed companies. If you'd like us to add MTVA, reply to your welcome email and we'll prioritize it.
History
Earnings history
- Q3 FY20262026-11-04EPS— vs $-0.94—Rev— vs ——EODHD
- Q2 FY20262026-08-05EPS$-0.90 vs $-0.85-5.9%Rev$0 vs ——EODHD
- Q1 FY20262026-05-13EPS$-0.79 vs $-0.75-5.3%Rev$0 vs ——EODHD
- Q4 FY20252025-12-30EPS— vs $-1.82—Rev$0 vs ——EODHD
- Q3 FY20252025-11-05EPS$-1.54 vs $-2.75+44.0%Rev$0 vs ——EODHD
- Q2 FY20252025-08-06EPS$-0.26 vs $-0.32+18.8%Rev$0 vs ——EODHD
- Q1 FY20252025-05-13EPS$-0.36 vs $-0.30-20.0%Rev$0 vs ——EODHD
- Q4 FY20242025-03-19EPS$-3.52 vs $-8.14+56.8%Rev$0 vs ——EODHD
- Q3 FY20242024-11-06EPS$-6.05 vs $-8.03+24.7%Rev$0 vs ——EODHD
- Q2 FY20242024-08-13EPS$-20.35 vs $-12.36-64.6%Rev$0 vs ——EODHD
- Q1 FY20242024-05-08EPS$-1.32 vs $-3.63+63.6%Rev$0 vs ——EODHD
- Q4 FY20232024-03-27EPS$-25.08 vs $-8.63-100.0%Rev$0 vs ——EODHD
- Q3 FY20232023-11-12EPS$-7.92 vs $-9.68+18.2%Rev$0 vs ——EODHD
- Q2 FY20232023-08-08EPS$-1.76 vs $-11.44+84.6%Rev— vs ——EODHD
- Q1 FY20232023-05-11EPS$-5.28 vs $-55.44+90.5%Rev— vs ——EODHD
- Q4 FY20222023-03-29EPS$4.93 vs $-1.20+100.0%Rev— vs ——EODHD
- Q3 FY20222022-11-13EPS$-308.00 vs $-448.80+31.4%Rev— vs ——EODHD
- Q2 FY20222022-08-15EPS$-0.12 vs $-5.10+97.7%Rev— vs ——EODHD
- Q1 FY20222022-05-24EPS$-0.17 vs $-0.16-6.3%Rev— vs ——EODHD
- Q3 FY20212021-11-14EPS$-422.40 vs $-475.20+11.1%Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | — | $-0.94 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $-0.90 | $-0.85 | -5.9% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-13 | $-0.79 | $-0.75 | -5.3% | $0 | — | — | EODHD |
| Q4 FY2025 | 2025-12-30 | — | $-1.82 | — | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $-1.54 | $-2.75 | +44.0% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-0.26 | $-0.32 | +18.8% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-13 | $-0.36 | $-0.30 | -20.0% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-03-19 | $-3.52 | $-8.14 | +56.8% | $0 | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-6.05 | $-8.03 | +24.7% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-08-13 | $-20.35 | $-12.36 | -64.6% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-1.32 | $-3.63 | +63.6% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-27 | $-25.08 | $-8.63 | -100.0% | $0 | — | — | EODHD |
| Q3 FY2023 | 2023-11-12 | $-7.92 | $-9.68 | +18.2% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-08 | $-1.76 | $-11.44 | +84.6% | — | — | — | EODHD |
| Q1 FY2023 | 2023-05-11 | $-5.28 | $-55.44 | +90.5% | — | — | — | EODHD |
| Q4 FY2022 | 2023-03-29 | $4.93 | $-1.20 | +100.0% | — | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $-308.00 | $-448.80 | +31.4% | — | — | — | EODHD |
| Q2 FY2022 | 2022-08-15 | $-0.12 | $-5.10 | +97.7% | — | — | — | EODHD |
| Q1 FY2022 | 2022-05-24 | $-0.17 | $-0.16 | -6.3% | — | — | — | EODHD |
| Q3 FY2021 | 2021-11-14 | $-422.40 | $-475.20 | +11.1% | — | — | — | EODHD |
Source: EODHD. MTVA reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MTVA.
$ curl https://api.spokenalpha.com/v1/companies/MTVAFAQ
Frequently asked about MTVA
Where can I find MetaVia Inc.'s (MTVA) earnings call transcripts?
Spoken Alpha indexes MTVA's earnings call transcripts at https://spokenalpha.com/companies/MTVA. Each call links to attributed speakers and parsed analyst Q&A. MetaVia Inc.'s own investor relations page is at https://ir.metaviatx.com/.
What sector is MTVA in?
MetaVia Inc. (MTVA) operates in the Healthcare sector (Biotechnology industry).